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ABSTRACT Staphylococcus aureus is a formidable human pathogen that uses secreted cytolytic factors to injure immune cells
and promote infection of its host. Of these proteins, the bicomponent family of pore-forming leukocidins play critical roles in
S. aureus pathogenesis. The regulatory mechanisms governing the expression of these toxins are incompletely defined. In this
work, we performed a screen to identify transcriptional regulators involved in leukocidin expression in S. aureus strain USA300.
We discovered that a metabolic sensor-regulator, RpiRc, is a potent and selective repressor of two leukocidins, LukED and
LukSF-PV. Whole-genome transcriptomics, S. aureus exoprotein proteomics, and metabolomic analyses revealed that RpiRc
influences the expression and production of disparate virulence factors. Additionally, RpiRc altered metabolic fluxes in the tricarboxylic acid cycle, glycolysis, and amino acid metabolism. Using mutational analyses, we confirmed and extended the observation that RpiRc signals through the accessory gene regulatory (Agr) quorum-sensing system in USA300. Specifically, RpiRc
represses the rnaIII promoter, resulting in increased repressor of toxins (Rot) levels, which in turn negatively affect leukocidin
expression. Inactivation of rpiRc phenocopied rot deletion and increased S. aureus killing of primary human polymorphonuclear leukocytes and the pathogenesis of bloodstream infection in vivo. Collectively, our results suggest that S. aureus senses
metabolic shifts by RpiRc to differentially regulate the expression of leukocidins and to promote invasive disease.
IMPORTANCE The bicomponent pore-forming leukocidins play pivotal roles in the ability of S. aureus to kill multiple host immune cells, thus enabling this pathogen to have diverse tissue- and species-tropic effects. While the mechanisms of leukocidinhost receptor interactions have been studied in detail, the regulatory aspects of leukocidin expression are less well characterized.
Moreover, the expression of the leukocidins is highly modular in vitro, suggesting the presence of regulators other than the
known Agr, Rot, and S. aureus exoprotein pathways. Here, we describe how RpiRc, a metabolite-sensing transcription factor,
mediates the repression of two specific leukocidin genes, lukED and pvl, which in turn has complex effects on the pathogenesis of
S. aureus. Our findings highlight the intricacies of leukocidin regulation by S. aureus and demonstrate the involvement of factors beyond traditional virulence factor regulators.
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S

taphylococcus aureus is a daunting human pathogen that causes
a range of diseases, from mild skin and soft tissue infections to
debilitating and life-threatening bacteremia. In order to establish
a successful infection, S. aureus secretes a variety of immunomodulatory proteins and virulence factors, a substantial number
of which target leukocytes (1, 2). A complex family of these secreted proteins is the bicomponent pore-forming leukocidins
(here referred to as leukocidins) (3, 4). These toxins consist of two
different subunits that are secreted as water-soluble monomers.
The binding subunit anchors to leukocytes through proteinaceous
host receptors, recruits the other subunit, oligomerizes, and sub-
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sequently forms ␤-barrel pores within the host plasma membrane,
leading to cell death (3, 4). Most S. aureus species carry five different leukocidins: leukocidin AB (LukAB, also known as LukHG),
leukocidin ED (LukED), Panton-Valentine leukocidin (LukSFPV, also known as PVL), and the gamma hemolysins HlgAB and
HlgCB. Unique and central to the action of these leukocidins is
their ability to lyse immune cells in a species-specific and celltype-specific manner (3, 5). For example, while all of the leukocidins can target human polymorphonuclear leukocytes (hPMNs or
neutrophils), LukAB, PVL, HlgAB, and HlgCB display greater tropism to human neutrophils than to murine neutrophils, whereas
®
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FIG 1 Leukocidin protein abundances and promoter activities vary during growth in vitro. (A) Quantitative mass spectrometry analyses (by LFQ) of
postexponentially grown USA300 JE2 culture filtrates. (B) Leukocidin promoter activity in TSB measured by luminescence of postexponentially grown USA300
harboring plasmids of leukocidin promoter sequences fused to the luciferase gene. The values shown are averages of two independent experiments each
performed with three colonies of each strain ⫾ the standard deviation.

LukED is active against neutrophils from all of the species tested
(6, 7). Similarly, the different leukocidins preferentially target specific immune cells on the basis of cell surface receptors (3, 5, 8–11).
Given their potential damaging effects, it is not surprising that
the expression of leukocidins is tightly regulated by a highly complex, multifaceted regulatory network involving two-component
systems (TCSs), winged helix-turn-helix (HTH) DNA-binding
transcription factors, and at least one effector small RNA. Vital to
the regulation of leukocidins is the master quorum-sensing regulatory system in S. aureus, which comprises the accessory gene
regulator (Agr) proteins (12). At quorum (mimicked by postexponentially growing bacteria in vitro), agr produces an autoinducing peptide that, in the process of activating its own synthesis,
leads to the production of the effector RNA molecule known as
RNAIII (12, 13). RNAIII acts directly and indirectly on many virulence genes, up- or downregulating their translation and protein
production (14, 15). Increased production of RNAIII leads to an
increase in the abundance of exoproteins (including toxins and
exoenzymes) and a decrease in the abundance of surface proteins
involved in immune evasion (12–17). One critical target of
RNAIII is the repressor of toxins (Rot) (14), which directly targets
the leukocidin promoters (17, 18). In addition to the Agr-Rot
regulatory network, the S. aureus exoprotein (Sae) expression TCS
(SaeRS-TCS) has been implicated in the regulation of leukocidins
(19–24). In contrast to Agr, which is a “self”-sensing system, the
SaeRS-TCS responds to host-derived molecules and/or conditions likely encountered in vivo, such as pH, osmolarity, and
neutrophil-derived proteins and peptides (21, 25, 26). Further
linking Agr, Rot, and Sae is the observation that Rot negatively
regulates one of the saeRS promoters, leading to robust repression
of toxins (27). In sum, early in S. aureus infection, the agr locus is
inactive, allowing enhanced production of surface molecules and
adhesins, while toxins are repressed by Rot. At later stages of infection, the Agr system is activated and the expression of secreted
virulence factors such as leukocidins is upregulated by RNAIIImediated inhibition of Rot translation (7, 17). This circuit is then
completed by relief of the inhibition of the sae locus, which leads
to the further upregulation of leukocidins (23).
The success of S. aureus as a versatile pathogen relies in part on
its ability to infect nearly all sites of the body. This adaptability
depends on the ability of S. aureus to fine-tune the production of
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its virulence factors by sensing and responding to a diversity of
external stimuli, leading to optimal pathogenesis, depending on
the environment it is inhabiting (13, 28, 29). Therefore, identifying and characterizing regulators of toxins that sense and respond
to disparate environmental conditions may shed light on S. aureus
pathogenesis, enabling better therapeutic approaches for S. aureus
clearance from specific infection sites.
In this study, we sought to identify transcriptional regulators of
leukocidins in USA300, which is the leading cause of the current
community-associated methicillin-resistant S. aureus epidemic in
the United States (here referred to as USA300). We demonstrated
that inactivation of a metabolic regulatory gene, rpiRc, increases
S. aureus cytotoxicity for human neutrophils. RpiRc belongs to a
family of transcriptional regulators with roles in the regulation of
enzymes involved in sugar catabolism in many bacterial species.
Using mutational analyses, we demonstrated that RpiRc differentially regulates the expression of leukocidins. Specifically, RpiRc is
a potent repressor of the lukED and lukSF-PV loci. Importantly,
we found that RpiRc-mediated gene regulation is critical to the
fine-tuning of S. aureus pathogenesis.
RESULTS

The protein levels and promoter activities of the leukocidins
vary during S. aureus growth in vitro. Postexponential-phase
S. aureus cultures produce and secrete a variety of virulence factors, a major class of which are the leukocidins. Proteomic analyses of S. aureus culture filtrates revealed that the comparative levels
of the five leukocidins differed greatly during the postexponentialphase growth of USA300 strain LAC in tryptic soy broth (TSB)
(Fig. 1A). Specifically, LukAB and LukSF-PV were highly abundant in culture filtrates, while minimal levels of LukED and
HlgACB were detected.
To test if these differential protein levels were due to differential regulation of the leukocidin promoters, we used toxin promoter sequences fused to luciferase reporter genes and measured
the respective leukocidin promoter activity (17, 30). As shown in
Fig. 1B, in the postexponential growth phase, the promoters of the
different toxins were active to various degrees, and for the most
part, expression profiles showed changes in protein levels
(Fig. 1A). Among the leukocidins, the lukSF promoter activity and
the corresponding PVL levels were the highest, whereas the lukED
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FIG 2 Identification of transcriptional regulators that enhance S. aureus cytotoxicity. (A) Primary intoxication screening of hPMNs with USA300 JE2
supernatants at a final concentration of 5% (vol/vol). Data points represent neutrophil death caused by an individual mutant relative to that caused by wild-type
(WT) bacteria (lower dotted line). Supernatants from each mutant were tested on hPMNs from four donors, and cell viability was measured with CellTiter
metabolic dye. A 2.2-fold cutoff was used to identify candidate mutants for further screening (upper dotted line). The data point indicated by the triangle
represents the cytotoxicity of a rot::bursa mutant. (B and C) Validation intoxication screening of hPMNs isolated from two donors with supernatants from select
S. aureus mutants. Wild-type and mutant bacteria were grown for 3 (B) and 6 (C) h postinoculation. Error bars indicate the standard error of the mean.

and hlgA promoters were minimally active, which was reflected in
their respective protein amounts (Fig. 1A and B). Of note, the
activation of the leukocidin promoters is highly dependent on the
growth medium used (see Fig. S1 in the supplemental material).
These results suggest that the differentially secreted leukocidins in
USA300 are due primarily to variance among toxin promoter activities.
Screen to identify transcriptional regulators that alter S. aureus cytotoxicity. The differential activity of the leukocidin promoters may be due to the action of transcription factors at these
promoters. In order to screen regulatory genes that may alter leukocidin production, we created a “regulator” sublibrary from the
USA300 Nebraska transposon mutant library collection (31). This
sublibrary consisted of 251 mutants of the JE2 strain (a laboratory
version of USA300 LAC) that included gene products with any
potential regulatory roles, including ones with nucleotide-binding
domains, putative or confirmed HTH motifs, two-component
regulatory systems, terminators, and antiterminators. For the
functional annotations of the sublibrary, see Table S1 in the supplemental material.
All of the leukocidins are known to target hPMNs. Therefore,

May/June 2016 Volume 7 Issue 3 e00818-16

we screened supernatants collected from the 251 mutants for the
ability to lyse hPMNs. Supernatants collected from the sublibrary
grown for 3 h were used to intoxicate hPMNs isolated from four
human donors. We found several mutants that exhibited altered
cytotoxicity for hPMNs. For this study, we chose candidates that
showed hypercytotoxicity with the goal of identifying novel repressors involved in the expression of lukED and hlgACB (see
Table S1 in the supplemental material).
Compared to wild-type-induced cytotoxicity, mutants with
changes in known leukocidin repressors, such as rot and sigB, were
identified as hypercytotoxic in our screening (see Table S1 in the
supplemental material), validating our assay. Of the mutations
that caused increased cytotoxicity, 10 regulators led to neutrophil
killing similar to that of a rot::bursa mutant (~2.2-fold increased
cytotoxicity, Fig. 2A). In order to validate these data, we collected
supernatants at both 3 and 6 h of bacterial growth. Of the 10
regulators tested, only rot::bursa and the mutation corresponding
to NE1142 (rpiRc::bursa) caused increased cytotoxicity for
hPMNs at both time points (Fig. 2B and C). Thus, we decided to
focus on characterizing RpiRc and its repressive effects on S. aureus virulence.
®
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FIG 3 RpiRc is a potent regulator of S. aureus secreted proteins. (A) Exoprotein profiles of USA300 JE2 wild-type (WT) and rpiR mutant bacteria, as assessed
by Coomassie staining. The asterisk indicates the approximate leukocidin protein size. (B) Exoprotein profile of USA300 LAC wild-type, rpiRc, and rpiRc⫹
isogenic strains. (C) Heat map of LAC wild-type and rpiRc mutant secretomes as assessed by mass spectrometry. (D to F) Levels of exoenzymes (D), surface and
immunomodulatory proteins (E), and cytotoxins (F) ⫾ the standard deviation in exoproteomes of wild-type versus rpiRc mutant USA300 LAC.

RpiRc controls the production of secreted virulence factors
in S. aureus. The RpiR class of proteins has been found in many
different bacterial species, including Gram-negative Escherichia
coli and Pseudomonas putida and Gram-positive Bacillus subtilis
(32–34). This family of proteins is traditionally thought to include
transcriptional regulators involved in sugar metabolism, although
their regulons, binding sites, and exact functions are poorly characterized. The RpiR prototype contains an N-terminal HTH
DNA-binding motif and a C-terminal sugar isomerase-sensing
(SIS) domain (33, 35). A recent study identified three RpiR homologs in S. aureus, namely, rpiRa, rpiRb, and rpiRc (36). Mutations of these genes in methicillin-susceptible S. aureus strain
UAMS-1 implicated these regulators in the control of the pentose
phosphate pathway (PPP). Interestingly, inactivation of rpiRc also
led to increased RNAIII synthesis and hemolysis and reduced biofilm formation (36).
To further evaluate the interactions among RNAIII, virulence,
and RpiRc in USA300, we first examined the exoproteomes of
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wild-type and rpiRc::bursa mutant strains. We observed that various secreted proteins were differentially produced by the strains.
The most dramatic difference in abundance was observed in protein bands corresponding to the size of leukocidins (~35 kDa).
There were notably higher levels of proteins in that size range in
the JE2 rpiRc::bursa culture filtrate than in that of wild-type JE2
(Fig. 3A), whereas mutations in the other rpiR genes had no effect
on these toxins.
To demonstrate that the observed phenotype of the JE2 rpiRc::
bursa mutant was due to the transposon-mediated disruption
of rpiRc, the mutated allele was transduced into USA300 LAC
strain AH1263 (referred to as LAC in this report), another
erythromycin-sensitive LAC clone (37). Compared to the wildtype strain, the isogenic LAC rpiRc::bursa mutant also exhibited
increased production of proteins that run at the size of leukocidins
(Fig. 3B). Importantly, this phenotype was fully complemented by
the insertion of rpiRc in single copy at the SaPI1 attachment site
(referred to as the rpiRc⫹ strain in this study) (Fig. 3B).

May/June 2016 Volume 7 Issue 3 e00818-16

FIG 4 Defining the RpiRc regulon and the RpiRc-associated metabolic changes. RNA-Seq of USA300 wild-type and rpiRc mutant bacteria. (A) Genomic map
depicting transcription profiles. The outer circle (blue) indicates the RPKM (number of reads per kilobase per million mapped reads) of the wild type, and the
inner circle (red) indicates the RPKM of the rpiRc mutant. The center circle is a heat map showing the fold differences in expression. Genes that were 5-fold
upregulated (blue arrows) or 5-fold downregulated (red arrows) are indicated. (B) Fold differences in metabolic flux between the wild type (WT) and the rpiRc
mutant based on RNA-Seq results. The enzyme classification (E.C.) numbers represent specific enzymatic reactions and their corresponding pathways. (C) Fold
differences in transcript (RNA-Seq) and protein (proteomics) abundance of the individual leukocidins between wild-type and rpiRc mutant bacteria.

To gain better insight into the effects of RpiRc on exoprotein
production in USA300, we analyzed the in vitro culture filtrates by
mass spectrometry. Exoproteins were collected from three independent colonies of wild-type LAC and the rpiRc mutant strain
grown to postexponential phase, and the protein profiles were
analyzed by label-free quantitative mass spectrometry. We observed tremendous reproducibility among the biological replicates, as demonstrated by the clustering of the proteins in the heat
map (Fig. 3C). We identified 96 (2-fold up or down in abundance)
of the total 483 secreted proteins of USA300 to be altered in the
mutant, of which 31 were positively impacted and 65 were negatively impacted in the rpiRc mutant (see Table S2 in the supplemental material). Among these proteins, we found increased production of most exoenzymes, such as proteases (4- to 6-fold
increase), while a few exoenzymes, such as coagulase, were lower
in abundance (Fig. 3D). Proteins involved in immune evasion and
adhesion (including superantigens, Sbi, protein A, and ClfB)
were, for the most part, lower in abundance in the rpiRc mutant
(Fig. 3E). We found a stark increase in the production of cytotoxins (leukocidins and phenol-soluble modulins) in the rpiRc mutant (Fig. 3F). Interestingly, RpiRc seems to differentially regulate
the production of leukocidins, as LukSF-PV and LukED were notably upregulated in the rpiRc mutant strain, whereas other leuko-
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cidins, such as gamma hemolysin and LukAB, were minimally
impacted in this strain (Fig. 3F).
Defining the RpiRc regulon. The regulon of RpiRc in S. aureus
is currently unknown. To gain a better understanding of the genes
differentially regulated by RpiRc, we performed transcriptome sequencing (RNA-Seq) of RNA isolated from postexponentialphase cultures of wild-type and rpiRc mutant USA300. From the
RNA-Seq analyses, we identified 476 genes altered (2-fold up- or
downregulated) in the rpiRc mutant versus the wild-type strain.
Among these genes, we found 82 to be repressed and 394 to be
upregulated in the mutant (see Table S3 in the supplemental material). Genes that were 5-fold up- or downregulated in the rpiRc::
bursa mutant are shown in Fig. 4A. Of these, the lukED and
lukSF-PV leukocidin transcripts were drastically upregulated. In
addition, genes involved in capsular polysaccharide biosynthesis
and some proteases, such as sspABC, were also upregulated. In
contrast, many genes involved in sugar metabolism and transport
and surface virulence proteins (such as spa) were downregulated
(see Table S3 in the supplemental material).
Since RpiRc is a regulator of metabolic enzymes, we wanted to
determine if there were any general trends in the up- or downregulation of certain metabolic pathways. To address this question, we performed in silico metabolic profiling analyses of the
®
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transcriptomic data (38–40). As shown in Fig. 4B (see Table S4 in
the supplemental material), we observed that three clusters of
metabolic pathways were differentially activated in wild-type and
rpiRc mutant bacteria. First, and notably, we observed a signature
of decreased tricarboxylic acid (TCA) cycle activity in the rpiRc
mutant. Second, and in contrast, several amino acid metabolic
pathways were more active in the mutant than in the wild type.
Third, we observed a slight but consistent activation of the glycolysis and gluconeogenesis pathways. While the fold differences in
metabolic fluxes in glycolysis/gluconeogenesis between wild-type
and rpiRc mutant bacteria are only moderate, we nevertheless observed that many genes in these two pathways were upregulated in
the rpiRc mutant (Fig. 4B; see Table S4 in the supplemental material). Of note, we observed no growth defect in vitro when comparing the wild-type strain and the isogenic strain lacking rpiRc
(see Fig. S2 in the supplemental material), consistent with observations reported previously (36). Taken together, mutation of
rpiRc seems to lead to decreased activity of the TCA cycle and an
increase in glycolysis/gluconeogenesis and certain amino acid biosynthetic pathways. In UAMS-1, RpiRc was observed to increase
the expression and activity of some PPP genes (36). In our analyses, while there were no notable PPP shifts, we observed potential
positive regulatory roles of RpiRc in the TCA cycle.
The RNA-Seq analyses also revealed differences in several virulence factors between the wild type and the mutant, the most
dramatic of which was the differential expression of some leukocidins (Fig. 4A; see Table S3 in the supplemental material). Specifically, and consistent with the proteomic analyses, we observed
a striking increase in the expression of lukSF-PV and lukED in the
mutant (Fig. 4C), further validating that RpiRc is involved in the
expression of these specific leukocidin-coding genes.
RpiRc represses leukocidin expression by acting on Rot
translation. We next validated the RNA-Seq data on the leukocidins by quantitative real-time PCR (qRT-PCR). Consistent with
the RNA-Seq and proteomic analysis results, levels of lukS-PV and
lukE mRNAs were ~6- to 7-fold higher in the rpiRc mutant than in
both the wild-type and rpiRc⫹ strains (Fig. 5A). In addition to the
leukocidins, we also monitored the expression of alpha-toxin (encoded by hla), another important virulence factor in S. aureus
(41). The hla gene was also found to be derepressed in the USA300
rpiRc mutant (Fig. 5A), data in line with the observation that deletion of rpiRc from strain UAMS-1 produces increased hemolytic
activity (36).
To further dissect the signaling pathway(s) downstream of
RpiRc, we measured the promoter activities of the master regulators of toxin gene expression, rnaIII, sae, and rot, in the rpiRc
mutant. Consistent with the finding that RNAIII transcript levels
are elevated in an rpiRc mutant of strain UAMS-1 (36), we observed 5-fold greater promoter activity of rnaIII in the USA300
rpiRc mutant than in the wild-type and rpiRc⫹ strains (Fig. 5B).
Moreover, we observed that while a rot transcriptional fusion was
unaffected in the USA300 rpiRc mutant, a rot translational fusion
was severely repressed in this background (Fig. 5B), consistent
with the RNAIII-mediated translational regulation of rot (14, 42,
43). Lastly, consistent with decreased levels of Rot, we observed
~2-fold greater sae promoter activity in the rpiRc mutant than in
the wild-type and rpiRc⫹ strains (Fig. 5B).
We noticed that the transcriptional profiles of the leukocidins
in the rpiRc mutant closely resembled that of the USA300 rot mutant (7, 17, 44), suggesting that RpiRc phenocopies the transcrip-
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tional effects of Rot (Fig. 5A). To further evaluate Rot functionality in the rpiRc mutant strain, we monitored the expression of a
gene positively regulated by Rot, spa, which encodes the immune
modulator protein A (45). Both RNA-Seq and qRT-PCR showed
that spa levels were significantly lower in both the rot and rpiRc
mutants (see Table S3 in the supplemental material; Fig. 5A). Collectively, these data suggest that in wild-type USA300, RpiRc represses the agr P3 promoter encoding RNAIII in a growth phasedependent manner, which in turn leads to relief of the inhibition
of rot translation and decreased sae expression, subsequently leading to the repression of specific leukocidins and other virulence
factors.
Mutation of rpiRc enhances S. aureus USA300-mediated virulence. Next we elucidated the contribution of RpiRc to USA300hPMN interactions, as neutrophils are innate immune cells critical for the containment of S. aureus (46). Consistent with the
increased expression and production of secreted leukocidins described above, supernatants from the isogenic USA300 rpiRc mutant were more cytotoxic to hPMNs than were supernatants from
wild-type USA300, a phenotype fully complemented in the rpiRc⫹
strain (Fig. 6A).
To further explore the role of RpiRc during USA300-hPMN
interactions, we infected hPMNs with wild-type and rpiRc mutant
bacteria at different multiplicities of infection and monitored
hPMN lysis. As shown in Fig. 6B, the rpiRc mutant also caused
greater lysis of hPMNs than the wild-type and rpiRc⫹ isogenic
strains did. Lastly, we measured the survival of bacteria after inducing their phagocytosis by hPMNs. These studies revealed that
the phagocytosed rpiRc mutant was better able to recover following ingestion by neutrophils than were the wild-type and rpiRc⫹
strains (Fig. 6C). Thus, RpiRc in a wild-type scenario represses
S. aureus virulence factors that enhance the killing of hPMNs.
We then tested the role of rpiRc in an in vivo murine bacteremia
model. Mice were infected intravenously with the wild-type
USA300, rpiRc::bursa, and rpiRc::bursa/rpiRc⫹ strains, and their
survival was monitored over time. Infection with the mutant
strain led to significantly more mouse deaths than the wild-type
and rpiRc⫹ strains, strongly supporting our ex vivo data showing
that RpiRc has critical roles in S. aureus pathogenesis (Fig. 6D).
To investigate whether RpiRc is important in other murine
models, we also infected mice intradermally with the wild-type,
rpiRc::bursa, and rpiRc⫹ strains and monitored abscess formation
and dermonecrosis postinfection. We observed that infection with
the rpiRc mutant led to significantly higher dermonecrotic lesion
scores than did infection with the wild-type and rpiRc⫹ strains
(Fig. 6E). The increased virulence of the rpiRc::bursa strain in
these models is likely to be due to the derepression of Hla (Fig. 3 to
5), as this toxin is critical for the pathogenesis of USA300 (41).
Mutation of rpiRc enhances S. aureus virulence in a murine
bloodstream infection model primarily through derepression
of LukED. To understand the role of RpiRc in the virulence of
non-USA300 strains, we created rpiRc mutant and complemented
isogenic versions of S. aureus Newman, a strain that has been
widely used to study the role of LukED in murine bacteremia
models (6, 7, 9). Analyses of exoproteins produced by these isogenic strains revealed that, as in USA300, mutation of rpiRc in
Newman results in greater production of leukocidins (Fig. 7A,
top), including increased levels of LukD (Fig. 7A, bottom) than in
the wild-type and complemented strains. Moreover, supernatants

May/June 2016 Volume 7 Issue 3 e00818-16

Downloaded from mbio.asm.org on June 5, 2018 - Published by mbio.asm.org

Balasubramanian et al.

FIG 5 RpiRc regulates leukocidin expression by acting on Rot translation. (A) qRT-PCR analyses of transcripts in the USA300 LAC strains indicated. The
relative abundance of the individual gene products was normalized to that of the wild type (WT). The experiment was performed with RNA extracted from three
individual colonies, each assayed in triplicate, ⫾ the standard deviation. (B) Time course comparing the expression of various promoters fused to luciferase or
fluorescence genes. The values are averages of two independent experiments, each performed with three independent colonies of each strain, ⫾ the standard
deviation.

collected from rpiRc mutant Newman cultures were more cytotoxic to hPMNs than wild-type culture filtrates were (Fig. 7C).
Mice were infected systemically with sublethal doses of wildtype Newman, the rpiRc mutant, and the isogenic rpiRc⫹ strain (1
⫻ 107 CFU), and bacterial burdens in organs were determined at
96 h postinfection. We observed significantly greater bacterial
burdens in the hearts and livers of mice infected with the rpiRc
mutant than in those of mice infected with the wild-type and
complemented isogenic strains (Fig. 7C and D). Infection of mice
with a higher dose (2.5 ⫻ 107 CFU) of the rpiRc mutant led to
more deaths of mice than did the infection of mice with the wildtype or complemented isogenic strain (Fig. 7E). The median sur-
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vival of mice infected with the rpiRc::bursa mutant was 67 h, in
contrast to the 131.5 h of wild-type-infected mice. The rpiRc⫹
strain “overcomplemented” the lethality phenotype, potentially
because of the slightly increased expression of rpiRc in this strain
(see Fig. S3 in the supplemental material).
To directly elucidate the role of LukED in the observed increased virulence of the rpiRc mutant strain, we generated an rpiRc
lukED double mutant and infected mice as described above. We
noticed that, compared to the rpiRc mutant, the double mutant
strain was severely attenuated (Fig. 7E), suggesting that the repression of lukED by RpiRc has important physiological consequences
in bloodstream infection. Collectively, these data demonstrate
®
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FIG 6 Inactivation of rpiRc enhances the virulence of USA300 LAC. (A) Intoxication of hPMNs (from six donors ⫾ the standard of the mean) with a 2-fold

titration of USA300 culture filtrates. Cell death was measured with CellTiter metabolic dye. (B) Infection of hPMNs (from three donors ⫾ the standard of the
mean) with the isogenic USA300 strains indicated under nonphagocytosing conditions. Cell death was measured as percent lactate dehydrogenase (LDH) release
from lysed hPMNs. Statistical analyses were performed by ANOVA with Dunnett’s multiple comparison test. The asterisk indicates a P value of ⬍0.05 for
wild-type (WT) versus rpiRc::bursa bacteria and for rpiRc::bursa versus rpiRc::bursa/rpiRc⫹ bacteria. (C) Growth rebound of the opsonized USA300 isogenic
strains indicated during infection of hPMNs (from three donors ⫾ the standard of the mean) at an MOI of 10 under phagocytosing conditions. Percent survival
is the CFU count enumerated at the different time points relative to the start of infection. Statistical analyses were performed by ANOVA with Dunnett’s multiple
comparison test. (D) Kaplan-Meier curve showing the percent survival of mice (10/group) infected retro-orbitally with ~5 ⫻ 107 CFU of the isogenic strains
indicated. Statistically significant differences between curves were determined by log rank (Mantel-Cox) test, and P values are shown. The results were corrected
for multiple comparisons by using the Bonferroni-corrected threshold (assumed a statistical significance of 0.05 divided by two comparisons; 0.025). (E) Scores
of murine skin lesions and dermonecrosis (five mice per group with two abscesses each) 48 h after intradermal infection with ~1 ⫻ 106 CFU of the strains
indicated. Each symbol is the average score per site of infection. Statistical analyses were performed with the Kruskal-Wallis test. *, P ⬍ 0.05; **, P ⬍ 0.005.
Representative pictures of skin lesions at 48 h postinfection are shown on the right.

that RpiRc is a critical transcriptional regulator involved in S. aureus pathogenesis.
DISCUSSION

S. aureus secretes a diverse array of virulence factors (47), including the bicomponent pore-forming leukocidins (3) that target leukocytes. Studying the leukocidin mode of action, as well as the
regulatory networks that govern their expression, will contribute
to the understanding of S. aureus pathogenesis. Here, we undertook a screening strategy to identify potential regulators involved
in the control of leukocidin expression (Fig. 2). We identified
RpiRc, a metabolic transcriptional regulator, as a potent repressor
of leukocidins (Fig. 3 to 5). Importantly, we demonstrated that
RpiRc-mediated gene regulation impacts S. aureus pathogenesis
in in vitro, ex vivo, and in vivo infection models. We observed that
the transcriptional profiles of the rpiRc mutant were analogous to
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those of a rot mutant (44), with the upregulation of virulence
factors such as exotoxins and downregulation of surface proteins
like protein A.
In our preliminary screen to identify mutations that altered
cytotoxicity, we set a cutoff of a 2.2-fold increase in cytotoxicity
for selection of candidates. This was based on the cytotoxicity of
the rot mutant, which resulted in a small fraction of mutants to be
screened further (10 of the 251). It is evident that there are additional mutants identified by our screening that did not make the
cutoff but are interesting regulators that will be the subject of
future studies pursued in our laboratory.
The wild-type and rpiRc mutant strain exoprotein and transcriptomic profiles described here provide additional insight into
the function of RpiRc in S. aureus. In the RNA-Seq analyses, in
addition to the leukocidins, we observed ⬎2-fold changes in
genes involved in metabolism, sugar transport, translation,
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FIG 7 Mutation of rpiRc enhances S. aureus Newman virulence in a murine bloodstream infection model through derepression of LukED. (A) At the top is the
exoprotein profile of postexponentially grown isogenic Newman strains stained with Coomassie blue (CB). The asterisk indicates the approximate leukocidin
size. At the bottom is an immunoblot (IB) detecting LukD in the same samples. (B) Intoxication of hPMNs (from six donors ⫾ the standard error of mean) with
a 2-fold titration of Newman culture filtrates. Cell death was measured with CellTiter metabolic dye. (C and D) Bacteria recovered from the livers (C) and hearts
(D) of female ND4 Swiss-Webster mice infected retro-orbitally with 1 ⫻ 107 CFU of the strains indicated. Each symbol represents a mouse (n ⫽ 10). Analyses of
statistical significance were performed with the Kruskal-Wallis test. *, P ⬍ 0.05; **, P ⬍ 0.005; ***, P ⬍ 0.0005. (E) Kaplan-Meier curve showing the percent
survival of mice (20 per group) infected retro-orbitally with 2.5 ⫻ 107 CFU of the isogenic strains indicated. Statistically significant differences between curves
were determined by log rank (Mantel-Cox) test, and P values are shown. The results were corrected for multiple comparisons by using the Bonferroni-corrected
threshold (assumed statistical significance of 0.05 divided by three comparisons; 0.0167), and the statistical significance of differences was determined. WT, wild
type.

transcription, TCSs, and other regulators. While we did not
validate all of the candidate genes, it is likely that RpiRc has
direct or indirect effects on sugar metabolism, as it has been
shown to be critical for the regulation of PPP genes (36). Validation and characterization of these targets may indicate other
roles for RpiRc in S. aureus and may provide clues to links
between metabolism and virulence.
The S. aureus virulence regulatory networks are complex and
involve multifaceted environmental signals that dictate the finetuned expression of virulence factors, including leukocidins. The
Agr-Rot pathway has been implicated as a critical component of
leukocidin regulation (3, 7). Thus, it is not surprising that RpiRc
also acts via this Agr-Rot pathway. However, there are many aspects of RpiRc-mediated regulation that have yet to be elucidated.
First, the ligand(s) that triggers this regulatory pathway is unknown. A previous study of S. aureus RpiRc suggested that the
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ligand may be a metabolic intermediate, given its roles in metabolism and its N-terminal SIS domain (36). Our transcriptomic
analyses indicate that there are drastic changes in genes involved
in sugar uptake and metabolism in this mutant, further validating
this idea. Second, it will be important to identify environmental
conditions that trigger the activation or deactivation of RpiRc.
Many transcriptional regulators that signal via the Agr system respond to a variety of conditions, including oxygen concentrations,
amino acid availability, iron concentration status, and pH (29, 48,
49). Third, we have uncovered only one signaling pathway by
which RpiRc acts on leukocidins. Whether this is the sole pathway
for RpiRc-mediated regulation of virulence or if RpiRc can signal
through other regulatory networks that operate under different in
vivo conditions remains to be elucidated. Fourth, while it is clear
that RpiRc represses RNAIII expression in S. aureus (Fig. 5B) (36),
the molecular mechanism by which this occurs remains elusive. It
®
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is imperative to determine how RpiRc interacts with and regulates
target promoters to determine direct versus indirect modes of
gene regulation.
In order to be a successful pathogen, S. aureus has to adapt to
the harsh environments encountered within the host. In recent
years, interest in S. aureus metabolism has reemerged, as distinct
links between metabolism and pathogenesis are increasingly identified (50, 51). In S. aureus, several transcriptional factors sense
metabolites and regulate virulence in response to these signals.
Examples of metabolite-sensing regulators in S. aureus are CcpA
and CcpE. These carbon catabolite repressors sense glycolytic intermediates, and in addition to regulating uptake of nutrients such
as glucose, they also regulate the synthesis of virulence factors (52,
53). Another well-studied nutrient sensor is the CodY transcriptional regulator, which responds to branched-chain amino acids
and GTP in S. aureus (54). In response to nutrient availability,
CodY regulates the synthesis of alpha-toxin and certain adhesins
via the agr system (55). Importantly, inactivation of many of these
regulators (including the ones cited above) alters S. aureus pathogenesis, supporting the notion that metabolism is intimately
linked with the pathogenic lifestyle of this bacterium. The data
presented here support the idea that RpiRc is a critical transcriptional regulator that may respond to various environmental conditions to increase, decrease, or fine-tune S. aureus virulence.
MATERIALS AND METHODS
Ethics statement. Buffy coats were obtained from anonymous donors
with informed consent from the New York Blood Center. Because all of
the samples were collected anonymously prior to their delivery, the New
York University Langone Medical Center (NYULMC) Institutional Review Board determined that our study was exempt from further ethics
approval requirements. All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee of
NYULMC. All experiments were performed according to NIH guidelines,
the Animal Welfare Act, and U.S. federal law.
Bacterial cultures and growth conditions. S. aureus strains were routinely grown at 37°C on tryptic soy agar (TSA) or in TSB with antibiotic
supplementation as specified. E. coli DH5␣ was used for cloning and
propagation of plasmids. E. coli bacteria were grown in Luria-Bertani
broth with appropriate antibiotics. Liquid cultures were grown in 5 ml of
growth medium in 15-ml tubes incubated at a 45° angle with shaking at
180 rpm. For all experiments involving the growth of S. aureus bacteria, a
1:100 dilution of overnight cultures was subcultured into fresh medium.
Construction of bacterial strains and plasmids. For all of the strains,
plasmids, and oligonucleotides used in this study, see Table S5 in the
supplemental material. The LAC rpiRc::bursa mutant strain was generated
by phage transduction of the JE2 rpiRc::bursa (NE1142) strain of the Nebraska Transposon Mutant Library with phage 80 into wild-type,
erythromycin-sensitive LAC clone AH1263 (37). Complementation of
rpiRc on the chromosome was performed with suicide plasmid pJC1306
(kindly provided by John Chen), which is used to stably integrate DNA
into the SaP1 site, resulting in a single-copy chromosomal insertion (56).
The construction of these strains is described in Text S1 in the supplemental material. A LAC ⌬rot::spec mutant strain was generated as described
previously (17). The mutation was then transduced into erythromycinsensitive LAC. The Newman lukED::kan rpiRc::bursa mutant strain was
generated by transducing lukED::kan from strain Newman (as described
in reference 7) with rpiRc::bursa from LAC (VJT42.71).
Culture conditions for cytotoxicity screening. The regulator mutant
library was plated in a 96-well plate format on TSA. Overnight cultures of
the mutants were grown in TSB on 2 independent days in 96-well roundbottom plates, subcultured into 96-well round-bottom plates, and grown
for 3 h. The plates were centrifuged at 4,000 rpm, and the supernatants
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were collected into two different 96-well tissue culture-treated plates to
give a 5% final concentration during intoxication and frozen. Supernatants from this regulator mutant library were then used to intoxicate
hPMNs isolated from four different donors. In the validation screening,
10 mutants from the primary screening were grown as described above
but for 3 and 6 h, and cytotoxicity to hPMNs from two donors was assayed.
Cytotoxicity assay. hPMNs were isolated as described in reference 57,
and cytotoxicity assays were performed as described previously (17, 57).
Briefly, 2 ⫻ 105 hPMNs were added to a final volume of 100 l/well of
RPMI (Gibco) supplemented with 10 mM HEPES. Cells were intoxicated
for 1 h at 37°C in 5% CO2. Ten microliters of CellTiter 96 Aqueous One
Solution (CellTiter; Promega) was added, and the mixture was incubated
at 37°C in 5% CO2 for 2 h. hPMN viability was assessed with a PerkinElmer EnVision 2103 Multilabel Reader.
Exoprotein isolation, Coomassie staining, and immunoblotting.
The proteins in the culture supernatants of bacteria grown for 5 h were
precipitated and analyzed as described in reference 17. Immunoblotting
was performed with polyclonal antibodies against LukD (1:7,500), which
were detected with a fluorescent Alexa Fluor 680-conjugated anti-rabbit
antibody (1:25,000).
Quantitative mass spectrometry analysis. Wild-type and rpiRc::bursa
mutant strain exoprotein isolates were analyzed in triplicate. Label-free
quantification (LFQ) intensities obtained by mass spectrometry were log2
transformed, and all missing values were replaced with values from the
normal distribution. Z scores were calculated for all values, hierarchical
clustering was performed, and heat maps were generated. For detailed
information, see Text S1 in the supplemental material.
RNA isolation, RNA-Seq, and data analyses. RNA isolation and sample preparation for RNA-Seq were performed as previously outlined by
Carroll et al. (58). For detailed information on the RNA-Seq methods
used, see Text S1 in the supplemental material.
qRT-PCR. A 10- to 100-ng sample of total RNA (depending on the
abundance of the target gene) purified as described above was used to
perform qRT-PCR in a one-step reaction with Reverse Transcriptase Mastermix (QuantiTect) and SYBR green master mix (Qiagen) in a 7300 RealTime PCR system (Applied Biosystems). For the primers used to detect
the specific mRNAs, see Table S5 in the supplemental material. Analysis
was performed by the 2⫺⌬⌬CT method, and target genes in each strain
were normalized to the corresponding genes in wild-type cells.
Reporter assays. Strains containing reporter plasmids were grown
overnight in different media containing 10 g/ml chloramphenicol (to
retain reporter plasmids) in 96-well round-bottom plates. Following subculture in fresh medium in 96-well black, flat-bottom plates (Corning),
fluorescence and luminescence were measured with a PerkinElmer EnVision 2103 Multilabel Reader immediately after subculture (T0) and every
2 h for 10 to 12 h.
Computational metabolic flux prediction. A computational method
called E-Flux2 was used to analyze the difference in intracellular metabolic
fluxes between the wild-type and rpiRc::bursa mutant strains (for details,
see Text S1 in the supplemental material). For a list of the metabolic
pathways with significant changes and the complete list, see Table S4 in
the supplemental material.
Ex vivo assays of S. aureus-hPMN interactions. Infection of hPMNs
with extracellular S. aureus was performed as described previously (30),
with RPMI supplemented with 10 mM HEPES and 5% human serum
albumin at an hPMN concentration of 2 ⫻ 105/well at 37°C in 5% CO2 for
1 h. The neutrophil-mediated S. aureus killing assay was performed as
described previously (30). For details, see Text S1 in the supplemental
material.
Murine models of systemic and skin infections. Five-week-old female ND4 Swiss-Webster mice (Harlan Laboratories) were anesthetized
intraperitoneally with 250 to 300 l of Avertin (2,2,2-tribromoethanol
dissolved in tert-amyl alcohol and diluted to a final concentration of 2.5%
[vol/vol] in sterile saline). For systemic and skin infections, 3-h S. aureus
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cultures were washed, resuspended in 1 ⫻ phosphate-buffered saline, and
normalized for corresponding CFU counts. For systemic infections,
100 l of inoculum was administered retro-orbitally. For experiments
evaluating bacterial burdens, mice were euthanized with CO2 at 96 h
postinfection and the organs indicated were harvested as described in
reference 57. For acute/survival experiments, mice infected retro-orbitally
were monitored every 4 to 6 h for signs of morbidity (hunched posture,
lack of movement, paralysis, and inability to acquire food or water), at
which time the animals were euthanized and survival curves were plotted
over time (in hours). For skin infections, bacteria grown and processed as
indicated above were mixed 1:1 with Cytodex 1 microcarrier beads
(Sigma) in accordance with the manufacturer’s instructions and 100 l
was injected intradermally. Lesions were monitored every 12 h, pictures
were taken, and 10 unbiased scientific volunteers were asked to score the
lesions in a blind study. The scoring key was as follows: 1, no visible
lesions; 2, milk skin lesions/dermonecrosis; 3, severe skin lesions/dermonecrosis.
Statistical analyses. The distribution of the data was first assessed to
determine if it was normal. If the distribution was normal, then one-way
or two-way analysis of variance (ANOVA; GraphPad Prism version 5.0;
GraphPad Software) was used. Dunnett’s test was used for group comparisons as a follow-up to ANOVA. If the distribution of the data was nonparametric, we used the Kruskal-Wallis test to determine the statistical
significance of the difference. The statistical significance of the difference
between survival curves was determined by the Logrank test. The results
were corrected for multiple comparisons by using the Bonferronicorrected threshold (assumed a statistical significance of 0.05 divided by
the number of comparisons).
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